Get startedLog in
    Picture of Shenzhen Hepalink Pharmaceutical Co logo

    9989 — Shenzhen Hepalink Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA

    Picture of Shenzhen Hepalink Pharmaceutical Co logoShenzhen Hepalink Pharmaceutical Co
    18/02/2025 10:29
    Feb 18 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd  002399.SZ :
    * H1710 INJECTION RECEIVED APPROVAL FOR CLINICAL TRIAL FROM
NMPA

Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shenzhen Hepalink Pharmaceutical Co

    See all news